Evidence map›Paper›PMID 42313797›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Asymmetric Deoxygenative Difunctionalization of 1,2-Dicarbonyl Compounds Enabled by Phosphinite and Chiral Salen-Molybdenum Catalyst Synergy.

Yi-Zhe Yu, Jiang-Tao Li, Yu-Qiang Yin, Chun-Xiang Zhuo

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yi-Zhe YuState Key Laboratory of Physical Chemistry of Solid Surfaces, Fujian Key Laboratory of Chemical Biology, and College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, P. R. China.
Jiang-Tao LiState Key Laboratory of Physical Chemistry of Solid Surfaces, Fujian Key Laboratory of Chemical Biology, and College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, P. R. China.
Yu-Qiang YinState Key Laboratory of Physical Chemistry of Solid Surfaces, Fujian Key Laboratory of Chemical Biology, and College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, P. R. China.
Chun-Xiang ZhuoState Key Laboratory of Physical Chemistry of Solid Surfaces, Fujian Key Laboratory of Chemical Biology, and College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, P. R. China.ORCID https://orcid.org/0000-0002-2805-9632

Funding

Fujian Provincial Natural Science Foundation of China 2025J02001Fundamental Research Funds for the Central Universities 20720250078National Key R&D Program of China 2021YFA1502500National Natural Science Foundation of China 22371238National Natural Science Foundation of China 224B2114National Natural Science Foundation of China 22571266
6 · The paper itself

Abstract

The 2-aryl benzofuran-3-ones serve as pivotal scaffolds in natural products and bioactive molecules, yet their synthesis and subsequent asymmetric functionalization are hindered by multi-step protocols and the lability of their derivatives lacking electron-rich substituents on the aromatic ring of benzofuran-3-one core. Herein, we report a phosphinite-mediated, Mo-catalyzed intermolecular asymmetric deoxygenative coupling reaction between 1,2-dicarbonyl compounds and 3-(methoxymethyl)indoles, thus providing a series of chiral 2-aryl benzofuran-3-ones with a chiral quaternary carbon center with generally good yields and enantioselectivities. Mechanistic studies reveal that phosphinite and the Mo-complex synergistically promote the in situ generation of key intermediates, while the formally tetravalent mononuclear Mo-complex serves as the key species governing the enantioselectivity of the reaction. This work expands the application of chiral salen-Mo catalysts in asymmetric catalysis, offering an efficient route to valuable chiral benzofuranone derivatives.

Indexed as

1,2‐dicarbonyl compoundsasymmetric deoxygenative couplingasymmetric molybdenum catalysischiral benzofuran‐3‐onessynergistic effects

Identifiers

PMID42313797
PMCPMC13427174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.